Cerebrospinal fluid markers for prediction of Alzheimer's disease
- 27 November 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 352 (1) , 67-69
- https://doi.org/10.1016/j.neulet.2003.08.011
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairmentActa Neurologica Scandinavica, 2003
- CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective StudyExperimental Neurology, 2000
- Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairmentNeuroscience Letters, 1999
- Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer DiseaseArchives of Neurology, 1999
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseNeurology, 1997
- Cerebrospinal protein tau is elevated in early Alzheimer's diseaseNeuroscience Letters, 1996
- Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individualsJAMA, 1995
- “Mini-mental state”Journal of Psychiatric Research, 1975